Skip to content

The Analgesic Effect of Preemptive Oxycodone at Different Doses in Thoracoscopic Surgery Patients and Its Impact on Perioperative Inflammatory Factors

The Analgesic Effect of Preemptive Oxycodone at Different Doses in Thoracoscopic Surgery Patients and Its Impact on Perioperative Inflammatory Factors

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112478
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

Group OL:Intravenous injection of oxycodone 0.05 mg/kg before anesthesia induction.
Group OM:Intravenous injection of oxycodone 0.1 mg/kg before anesthesia induction.
Group OH:Intravenous injection of oxycodone 0.15 mg/kg before anesthesia induction.
Group S:Intravenous injection of sufentanil 0.1 µg/kg before anesthesia induction.
Group N:Intravenous injection of an equal volume of saline before anesthesia induction.

Sponsors

The Second Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for tracheal intubation under general anesthesia for thoracoscopic wedge resection of the lung. 2. Age 18 to 65 years, regardless of gender. 3. Body mass index (BMI) between 18 kg/m² and 30 kg/m². 4. ASA classification I to II. 5. Voluntarily signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Presence of chronic pain. 2. Presence of severe cardiovascular diseases. 3. Presence of severe respiratory diseases or other serious systemic conditions. 4. History of gastrointestinal bleeding or peptic ulcer disease within the past 2 months. 5. Dependence on alcohol or opioid drugs. 6.Long-term use of other psychiatric medications. 7.Allergy to any of the medications used in the study.

Design outcomes

Primary

MeasureTime frame
Postoperative VAS score changes;

Secondary

MeasureTime frame
Levels of inflammatory factors IL-6, IL-10, and TNF-a;Use of rescue analgesics;Ramsay sedation scale;Recovery time;Incidence of adverse reactions;Postoperative pulmonary complications;Length of hospital stay;

Countries

China

Contacts

Public ContactYongfa Zhang

The Second Affiliated Hospital of Shantou University Medical College

10yfzhang1@stu.edu.cn+86 137 5045 3746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026